BG105310A - Process for the preparation of a non-crystalline anhydrate from paroxetine hydrochloride - Google Patents

Process for the preparation of a non-crystalline anhydrate from paroxetine hydrochloride

Info

Publication number
BG105310A
BG105310A BG105310A BG10531001A BG105310A BG 105310 A BG105310 A BG 105310A BG 105310 A BG105310 A BG 105310A BG 10531001 A BG10531001 A BG 10531001A BG 105310 A BG105310 A BG 105310A
Authority
BG
Bulgaria
Prior art keywords
paroxetine hydrochloride
preparation
crystalline anhydrate
propan
solvate
Prior art date
Application number
BG105310A
Other languages
Bulgarian (bg)
English (en)
Inventor
Victor JACEWICZ
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817196.0A external-priority patent/GB9817196D0/en
Priority claimed from GBGB9828777.4A external-priority patent/GB9828777D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG105310A publication Critical patent/BG105310A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG105310A 1998-08-07 2001-03-06 Process for the preparation of a non-crystalline anhydrate from paroxetine hydrochloride BG105310A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9817196.0A GB9817196D0 (en) 1998-08-07 1998-08-07 Novel process
GBGB9828777.4A GB9828777D0 (en) 1998-12-29 1998-12-29 Novel compounds
PCT/GB1999/002592 WO2000008017A1 (en) 1998-08-07 1999-08-06 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride

Publications (1)

Publication Number Publication Date
BG105310A true BG105310A (en) 2001-12-29

Family

ID=26314179

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105310A BG105310A (en) 1998-08-07 2001-03-06 Process for the preparation of a non-crystalline anhydrate from paroxetine hydrochloride

Country Status (24)

Country Link
EP (2) EP1100796B1 (xx)
JP (1) JP2002522434A (xx)
KR (1) KR20010072323A (xx)
CN (1) CN1321155A (xx)
AP (2) AP2001002072A0 (xx)
AT (1) ATE239016T1 (xx)
AU (1) AU5428999A (xx)
BG (1) BG105310A (xx)
BR (1) BR9912858A (xx)
CA (1) CA2339857A1 (xx)
DE (1) DE69907467T2 (xx)
DK (1) DK1100796T3 (xx)
EA (1) EA200100221A1 (xx)
ES (1) ES2198940T3 (xx)
HK (1) HK1038230A1 (xx)
HU (1) HUP0105466A3 (xx)
ID (1) ID27914A (xx)
IL (1) IL141286A0 (xx)
NO (1) NO20010629L (xx)
PL (1) PL345885A1 (xx)
PT (1) PT1100796E (xx)
SK (1) SK1972001A3 (xx)
TR (1) TR200100444T2 (xx)
WO (1) WO2000008017A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384711A1 (en) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Optical resolution of a piperidine derivative
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
ATE405577T1 (de) * 2000-11-17 2008-09-15 Lilly Co Eli Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung
CA2502219C (en) 2002-10-16 2012-05-29 Takeda Pharmaceutical Company Limited A process for producing an amorphous isomer of lansoprazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
AP9901604A0 (en) * 1997-01-15 1999-09-30 Smithkline Beecham Plc Paroxetine compositions.
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法

Also Published As

Publication number Publication date
EA200100221A1 (ru) 2001-08-27
EP1321465A2 (en) 2003-06-25
BR9912858A (pt) 2001-11-20
ES2198940T3 (es) 2004-02-01
PL345885A1 (en) 2002-01-14
DK1100796T3 (da) 2003-08-25
PT1100796E (pt) 2003-09-30
EP1100796B1 (en) 2003-05-02
HUP0105466A3 (en) 2002-11-28
IL141286A0 (en) 2002-03-10
ID27914A (id) 2001-05-03
CN1321155A (zh) 2001-11-07
AP0102072A0 (en) 2001-02-06
TR200100444T2 (tr) 2001-07-23
DE69907467T2 (de) 2004-03-11
JP2002522434A (ja) 2002-07-23
ATE239016T1 (de) 2003-05-15
DE69907467D1 (de) 2003-06-05
WO2000008017A1 (en) 2000-02-17
SK1972001A3 (en) 2001-08-06
HK1038230A1 (en) 2002-03-08
AU5428999A (en) 2000-02-28
HUP0105466A2 (hu) 2002-05-29
NO20010629L (no) 2001-03-20
CA2339857A1 (en) 2000-02-17
KR20010072323A (ko) 2001-07-31
AP2001002072A0 (en) 2001-03-31
EP1321465A3 (en) 2003-09-03
EP1100796A1 (en) 2001-05-23
NO20010629D0 (no) 2001-02-06

Similar Documents

Publication Publication Date Title
PL319384A1 (en) Steroic compositions from soap mass
ES2114471A1 (es) Nuevos compuestos de paroxetina y procedimiento para su preparacion.
CZ258896A3 (en) Morpholine derivatives, process of their preparation and pharmaceutical compositions containing thereof
MY124151A (en) Epothilone derivatives
PL343726A1 (en) 1-[(1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
DE69709938D1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
HUP0100760A3 (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9903417A2 (hu) Új üvegösszetétel alkalmazása fogtechnikai üvegpillérek és támpillérek előállítására és eljárás az üvegpillérek előállítására
BG105310A (en) Process for the preparation of a non-crystalline anhydrate from paroxetine hydrochloride
MY125975A (en) Crystalline form vii of cabergoline
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
ZA962059B (en) Control of expansion in concrete due to alkali silica reaction
BG105204A (en) Salts of paroxetine
NZ505200A (en) Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
BG104604A (en) Process for the preparation of paroxetin hydrochloride
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
MXPA02006965A (es) Solvato de etanol de (-) -cis-2 -(2-clorofenil) -5, 7-dihidroxi -8[4r-(3s -hidroxi -1-metil] piperidinil] -4h-1 -benzopiran-4 -ona.
DE69728271D1 (en) Kristallines (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4[4-(2-pyrrolidin-1-yl)ethoxy] phenyl-chroman-wasserstoffumarate
SI1286965T1 (en) Piperidine compounds and process for providing such
NO20012028D0 (no) Fremgangsmåte for fremstilling av 4-((2',5'-diamino-6'- halogenpyrimidin-4'-yl)amino)-cyclopent-2-enyl-metanoler
PL318280A1 (en) Novel polymorphous modifications of lesopitrone dihydrochloride and theirhydrogenated forms, methods of obtaining them and compositions containing them
TW374764B (en) Antitumor and antileukaemic compounds, their preparation and pharmaceutical composition containing them
AU7025800A (en) Process for the preparation of 1-methyl-3-carbomethoxy-4-(4'-fluorophenyl)-piperidine